{"id":29,"date":"2006-05-29T21:39:31","date_gmt":"2006-05-29T12:39:31","guid":{"rendered":"http:\/\/haruko.km2m.net\/2006\/05\/29\/%e3%83%99%e3%82%ad%e3%82%b5%e3%83%bc%e3%83%ab-h18\/"},"modified":"2006-05-29T21:39:31","modified_gmt":"2006-05-29T12:39:31","slug":"%e3%83%99%e3%82%ad%e3%82%b5%e3%83%bc%e3%83%ab-h18","status":"publish","type":"post","link":"https:\/\/haruko.km2m.net\/?p=29","title":{"rendered":"\u30d9\u30ad\u30b5\u30fc\u30eb H18"},"content":{"rendered":"

\u653e\u5c04\u6027\u514d\u75ab\u7642\u6cd5\u85ac\u300c\u30d9\u30ad\u30b5\u30fc\u30eb\u300d\u306e\u958b\u767a\u306b\u3064\u3044\u3066<\/p>\n

tositumomab\uff08Bexxar\u3001\u30d9\u30ad\u30b5\u30fc\u30eb\uff09\u306f\u3001\u6297CD20\u6297\u4f53\u306b\u653e\u5c04\u6027\u7269\u8cea\u30e8\u30a6\u7d20131\u3092\u62b1\u5408\u3055\u305b\u305f\u653e\u5c04\u6027\u514d\u75ab\u7642\u6cd5\u85ac\u3067\u3059\u3002\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\uff08\u30ea\u30c4\u30ad\u30b5\u30f3\uff09\u306f\u3001\u6b63\u5e38\u306a\uff22\u7d30\u80de\u304a\u3088\u3073\u5927\u534a\u306e\uff22\u7d30\u80de\u6027\u30ea\u30f3\u30d1\u816b\u7d30\u80de\u306b\u767a\u73fe\u3057\u3066\u3044\u308bCD20\u6297\u539f\u3092\u6a19\u7684\u3068\u3057\u3066\u4f5c\u7528\u304c\u73fe\u308c\u308b\u85ac\u5264\u3067\u3059\u304c\u3001\u30d9\u30ad\u30b5\u30fc\u30eb\u306f\u6a19\u7684\u3092\u767a\u73fe\u3057\u3066\u3044\u308b\u7d30\u80de\u306e\u307f\u306a\u3089\u305a\u3001\u6a19\u7684\u3092\u767a\u73fe\u3057\u3066\u3044\u306a\u3044\u96a3\u63a5\u3059\u308b\u816b\u760d\u7d30\u80de\u306b\u5bfe\u3057\u3066\u3082\u653e\u5c04\u7dda\u304c\u4f5c\u7528\u3057\u3066\u3001\u6297\u816b\u760d\u52b9\u679c\u304c\u73fe\u308c\u308b\u3053\u3068\u304c\u671f\u5f85\u3055\u308c\u308b\u85ac\u5264\u3067\u3059\u3002\u30d9\u30ad\u30b5\u30fc\u30eb\u306f\u3001\u540c\u3058\u653e\u5c04\u6027\u514d\u75ab\u7642\u6cd5\u85ac\u306b\u5c5e\u3059\u308b\u30bc\u30f4\u30a1\u30ea\u30f3\u3068\u7570\u306a\u308a\u03b3\u7dda\u3092\u7167\u5c04\u3059\u308b\u305f\u3081\u3001\u653e\u5c04\u7dda\u306e\u906e\u853d\u306a\u3069\u306b\u3001\u3088\u308a\u914d\u616e\u304c\u5fc5\u8981\u3068\u306a\u308a\u307e\u3059\u3002<\/p>\n

\u7c73\u56fd\u3067\u306f\u30012004\u5e74\u306bFDA\u306b\u3088\u3063\u3066\u3001\u4e3b\u306b\u518d\u767a\u3001\u96e3\u6cbb\u6027\u306e\u4f4e\u60aa\u6027\u5ea6\u30ea\u30f3\u30d1\u816b\u306e\u60a3\u8005\u3055\u3093\u3092\u5bfe\u8c61\u306b\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30bc\u30f4\u30a1\u30ea\u30f3\u306f\u539a\u751f\u52b4\u50cd\u7701\u3078\u306e\u7533\u8acb\u304c\u7d42\u4e86\u3057\u3066\u3044\u307e\u3059\u304c\u3001\u30d9\u30ad\u30b5\u30fc\u30eb\u306e\u56fd\u5185\u3067\u306e\u958b\u767a\u306f\u672a\u3060\u884c\u308f\u308c\u3066\u3044\u307e\u305b\u3093\u30022005\u5e742\u6708\u306b\u56fd\u969b\u7684\u306a\u533b\u5b66\u8a8c\u3067\u3042\u308b\u300eNew England Journal of Medicine\u300f\u8a8c\u306b\u3001\u672a\u6cbb\u7642\u306e\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306e\u60a3\u8005\u3055\u3093\u3092\u5bfe\u8c61\u3068\u3057\u305f\u81e8\u5e8a\u8a66\u9a13\u306e\u7d50\u679c\u304c\u767a\u8868\u3055\u308c\u30015\u5e74\u7121\u9032\u884c\u751f\u5b58\u7387\u304c59\u30d1\u30fc\u30bb\u30f3\u30c8\u3068\u3044\u3046\u7d50\u679c\u304c\u793a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n

\n131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma
\nMark S. Kaminski, M.D., Melissa Tuck, M.A., Judith Estes, M.S.N., N.P., Arne Kolstad, M.D., Ph.D., Charles W. Ross, M.D., Kenneth Zasadny, Ph.D., Denise Regan, B.S., Paul Kison, B.S., Susan Fisher, B.A., Stewart Kroll, M.A., and Richard L. Wahl, M.D. <\/p>\n

\u30b0\u30eb\u30fc\u30d7\u30fb\u30cd\u30af\u30b5\u30b9\u3067\u306f\u3001\u30d9\u30ad\u30b5\u30fc\u30eb\u306e\u56fd\u5185\u3067\u306e\u65e9\u671f\u306e\u958b\u767a\u3092\u6c42\u3081\u6d3b\u52d5\u3057\u3066\u304d\u307e\u3057\u305f\u30022006\u5e741\u6708\u306b\u958b\u50ac\u3055\u308c\u305f\u539a\u751f\u52b4\u50cd\u7701\u306e\u7b2c7\u56de\u672a\u627f\u8a8d\u85ac\u4f7f\u7528\u554f\u984c\u691c\u8a0e\u4f1a\u8b70\u306b\u304a\u3044\u3066\u3001\u300c\u540c\u7a2e\u306e\u85ac\u5264\u3067\u3042\u308b\u30bc\u30f4\u30a1\u30ea\u30f3\u3068\u306e\u6709\u610f\u5dee\u306f\u660e\u3089\u304b\u3067\u306f\u306a\u3044\u300d\u3068\u306e\u30ef\u30fc\u30ad\u30f3\u30b0\u30b0\u30eb\u30fc\u30d7\u306e\u5831\u544a\u3092\u53d7\u3051\u3001\u300c\u672a\u627f\u8a8d\u85ac\u4f7f\u7528\u554f\u984c\u691c\u8a0e\u4f1a\u8b70\u306b\u3088\u308b\u8fc5\u901f\u5bfe\u5fdc\u306e\u30b9\u30ad\u30fc\u30e0\u306e\u5bfe\u8c61\u3068\u3059\u308b\u5fc5\u8981\u306f\u306a\u3044\u300d\u3068\u306e\u7d50\u8ad6\u304c\u51fa\u3055\u308c\u307e\u3057\u305f\u3002\u672a\u627f\u8a8d\u85ac\u4f7f\u7528\u554f\u984c\u691c\u8a0e\u4f1a\u8b70\u306e\u7d50\u8ad6\u306a\u3069\u3092\u53d7\u3051\u3001\u30b0\u30e9\u30af\u30bd\u30fb\u30b9\u30df\u30b9\u30af\u30e9\u30a4\u30f3\u793e\u3067\u306f\u30d9\u30ad\u30b5\u30fc\u30eb\u306e\u56fd\u5185\u3067\u306e\u958b\u767a\u3092\u691c\u8a0e\u3057\u3066\u304d\u307e\u3057\u305f\u3002\u30b0\u30e9\u30af\u30bd\u30fb\u30b9\u30df\u30b9\u30af\u30e9\u30a4\u30f3\u793e\u3068\u30b0\u30eb\u30fc\u30d7\u30fb\u30cd\u30af\u30b5\u30b9\u3068\u3067\u8a71\u3057\u5408\u3044\u306e\u5834\u3092\u3082\u3061\u3001\u30b0\u30eb\u30fc\u30d7\u30fb\u30cd\u30af\u30b5\u30b9\u304b\u3089\u306e\u8981\u671b\u306b\u5bfe\u3057\u3066\u3001\u30b0\u30e9\u30af\u30bd\u30fb\u30b9\u30df\u30b9\u30af\u30e9\u30a4\u30f3\u793e\u3088\u308a\u4e0b\u8a18\u306e\u56de\u7b54\u3092\u3044\u305f\u3060\u304d\u307e\u3057\u305f<\/p>\n

\u73fe\u5728\u3001\u653e\u5c04\u6027\u7269\u8cea\u306e\u53d6\u308a\u6271\u3044\u3084\u904b\u642c\u306a\u3069\u306e\u4e8b\u60c5\u306b\u3088\u308a\u3001\u30d9\u30ad\u30b5\u30fc\u30eb\u304c\u627f\u8a8d\u3055\u308c\u3066\u3044\u308b\u306e\u306f\u7c73\u56fd\u3068\u30ab\u30ca\u30c0\u3060\u3051\u3067\u3059\u3002\u81ea\u7531\u8a3a\u7642\u306e\u5f62\u3067\u30d9\u30ad\u30b5\u30fc\u30eb\u306e\u6d77\u5916\u3067\u306e\u4f7f\u7528\u306b\u3064\u3044\u3066\u8003\u616e\u306a\u3055\u308b\u5834\u5408\u306b\u306f\u3001\u307e\u305a\u306f\u4e3b\u6cbb\u533b\u306e\u5148\u751f\u3068\u3088\u304f\u8a71\u3057\u5408\u308f\u308c\u3066\u304f\u3060\u3055\u3044\u3002\u4e3b\u6cbb\u533b\u306e\u5148\u751f\u304c\u4e86\u627f\u3055\u308c\u307e\u3057\u305f\u3089\u3001\u4e3b\u6cbb\u533b\u306e\u5148\u751f\u306b\u30d9\u30ad\u30b5\u30fc\u30eb\u306e\u6cbb\u7642\u304c\u53ef\u80fd\u306a\u6d77\u5916\u306e\u533b\u7642\u6a5f\u95a2\u3068\u3001\u76f4\u63a5\u30b3\u30f3\u30bf\u30af\u30c8\u3092\u3068\u3063\u3066\u3044\u305f\u3060\u3044\u3066\u304f\u3060\u3055\u3044\u3002\u30d9\u30ad\u30b5\u30fc\u30eb\u306e\u6cbb\u7642\u304c\u53ef\u80fd\u306a\u533b\u7642\u6a5f\u95a2\u304a\u3088\u3073\u9023\u7d61\u5148\u306b\u3064\u304d\u307e\u3057\u3066\u306f\u3001\u7c73\u56fdMD\u30a2\u30f3\u30c0\u30fc\u30bd\u30f3\u304c\u3093\u30bb\u30f3\u30bf\u30fc\u306e\u4ed6\u306b\u3001\u30b0\u30e9\u30af\u30bd\u30fb\u30b9\u30df\u30b9\u30af\u30e9\u30a4\u30f3\u793e\u3088\u308a\u3044\u304f\u3064\u304b\u60c5\u5831\u63d0\u4f9b\u3092\u53d7\u3051\u3066\u304a\u308a\u307e\u3059\u306e\u3067\u3001\u4e3b\u6cbb\u533b\u306e\u5148\u751f\u3088\u308a\u30b0\u30eb\u30fc\u30d7\u30fb\u30cd\u30af\u30b5\u30b9\u307e\u3067\u304a\u554f\u3044\u5408\u308f\u305b\u304f\u3060\u3055\u3044\u3002<\/p>\n

\u306a\u304a\u3001\u7c73\u56fd\u3067\u306e\u30d9\u30ad\u30b5\u30fc\u30eb\u306e\u85ac\u4fa1\u306f\u3001\u30ec\u30c3\u30c9\u30d6\u30c3\u30af\uff08\u7c73\u56fd\u3067\u306e\u85ac\u4fa1\u53ce\u8f09\u672c\uff09\u306b\u3088\u308a\u307e\u3059\u3068\u30011\u56de\u306e\u6cbb\u7642\u306b\u3064\u304d31,200US\u30c9\u30eb\u3067\u3001\u65e5\u672c\u5186\u306b\u63db\u7b97\u3057\u3066\u304a\u3088\u305d363\u4e07\u5186\uff082006\u5e747\u670822\u65e5\u30ec\u30fc\u30c8\uff09\u306b\u306a\u308a\u307e\u3059\u3002\u307e\u305f\u3001\u4e0b\u8a18\u56de\u7b54\u66f8\u4e2d\u306e\u30bc\u30f4\u30a1\u30ea\u30f3\u3068\u30d9\u30ad\u30b5\u30fc\u30eb\u306e\u6bd4\u8f03\u81e8\u5e8a\u8a66\u9a13\u306b\u3064\u3044\u3066\u306f\u3001\u3053\u3061\u3089\u3067\u3059\u3002<\/p>\n

Comparative Trial Between Bexxar and Zevalin<\/p>\n

http:\/\/homepage3.nifty.com\/webpage3\/nexus\/topicsdetail08.html<\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

\u653e\u5c04\u6027\u514d\u75ab\u7642\u6cd5\u85ac\u300c\u30d9\u30ad\u30b5\u30fc\u30eb\u300d\u306e\u958b\u767a\u306b\u3064\u3044\u3066 tositumomab\uff08Bexxar\u3001\u30d9\u30ad\u30b5\u30fc\u30eb\uff09\u306f\u3001\u6297CD20\u6297\u4f53\u306b\u653e\u5c04\u6027\u7269\u8cea\u30e8\u30a6\u7d20131\u3092\u62b1\u5408\u3055\u305b\u305f\u653e\u5c04\u6027\u514d\u75ab\u7642\u6cd5\u85ac\u3067\u3059\u3002\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\uff08\u30ea\u30c4\u30ad\u30b5\u30f3\uff09\u306f\u3001\u6b63\u5e38\u306a\uff22\u7d30\u80de\u304a\u3088\u3073 … <\/p>\n

“\u30d9\u30ad\u30b5\u30fc\u30eb H18” \u306e<\/span>\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-29","post","type-post","status-publish","format-standard","hentry","category-4"],"_links":{"self":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/posts\/29","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=29"}],"version-history":[{"count":0,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/posts\/29\/revisions"}],"wp:attachment":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=29"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=29"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=29"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}